Effectiveness of Cabectocin vs oxytocin in prevention of primary postpartum haemorrhage after vaginal delivery. A randomised control clinical trial in Lagos Island Maternity hospital.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202410557388132

Enrollment

300

Registered

2024-10-03

Start date

2024-11-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Post partum haemorrhage

Interventions

Control

Experiment

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: - Pregnant women in labour with cervical dilation of 5cm or more. - Patients who give consent

Exclusion criteria

Exclusion criteria: - Women with known bleeding disorders. - Patients who sustained genital tract lacerations associated with significant bleeding. - Women with known cardiac disease. - Intrauterine foetal death before onset of labour. - Women who had caesarean section in labour. - Refusal of consent

Design outcomes

Primary

Measure	Time frame
Amount of blood loss of 500mls or more	—

Secondary

Measure	Time frame
Need for additional oxytocic. ;Adverse effects such as vomiting, headache, tachycardia, hypotension, and hot flushes, ;Need for blood transfusion	—

Countries

Nigeria

Contacts

Public ContactPrecious Ajeigbe

Assistant

wemimoajeigbe@gmail.com+2348084206861

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026